Active ingredientTrifaroteneCat. No. P-T201-001CAS 895542-09-3Family · Pharmaceutical analytical standards
Trifarotene
A fourth-generation topical retinoid that selectively activates the retinoic acid receptor RAR-gamma, approved in the United States in October 2019 for the treatment of acne vulgaris. This family brings together the active ingredient and other impurities.
Did you know?Although it was born as an acne treatment, it has received orphan drug designation for congenital ichthyosis, a rare skin disease, in both the United States and Europe.
Go to the active ingredient →Active ingredientTrifaroteneCat. No. P-T201-001CAS 895542-09-3
ImpurityTrifarotene Impurity 1Cat. No. P-T201-002CAS 850012-53-2
ImpurityTrifarotene Impurity 2Cat. No. P-T201-003CAS 895543-00-7
ImpurityTrifarotene Impurity 3Cat. No. P-T201-004CAS 895542-84-4
ImpurityTrifarotene Impurity 4Cat. No. P-T201-005CAS 895542-96-8
ImpurityTrifarotene Biphenyl Acid ImpurityCat. No. P-T201-006CAS 895543-28-9
ImpurityTrifarotene DecanoateCat. No. P-T201-008
ImpurityTrifarotene Des Bromo Acid ImpurityCat. No. P-T201-009CAS 46994-29-0
ImpurityTrifarotene Hydroxy Pyrrolidine Ester ImpurityCat. No. P-T201-010CAS 895542-69-5
ImpurityTrifarotene Impurity 5Cat. No. P-T201-011CAS 895542-08-2
ImpurityTrifarotene Impurity 6Cat. No. P-T201-012
ImpurityTrifarotene Impurity 7Cat. No. P-T201-013CAS 895543-08-5
ImpurityTrifarotene Impurity 8Cat. No. P-T201-014
ImpurityTrifarotene Impurity 9Cat. No. P-T201-015
ImpurityTrifarotene Impurity 10Cat. No. P-T201-016
ImpurityTrifarotene OctanoateCat. No. P-T201-017
ImpurityTrifarotene Pyrrolidine Ester ImpurityCat. No. P-T201-018CAS 3016428-47-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.